GB201614687D0 - fHbp scaffold - Google Patents

fHbp scaffold

Info

Publication number
GB201614687D0
GB201614687D0 GBGB1614687.0A GB201614687A GB201614687D0 GB 201614687 D0 GB201614687 D0 GB 201614687D0 GB 201614687 A GB201614687 A GB 201614687A GB 201614687 D0 GB201614687 D0 GB 201614687D0
Authority
GB
United Kingdom
Prior art keywords
fhbp
scaffold
fhbp scaffold
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1614687.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford University Innovation Ltd
Original Assignee
Oxford University Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford University Innovation Ltd filed Critical Oxford University Innovation Ltd
Priority to GBGB1614687.0A priority Critical patent/GB201614687D0/en
Publication of GB201614687D0 publication Critical patent/GB201614687D0/en
Priority to US16/328,340 priority patent/US12497432B2/en
Priority to BR112019003957-0A priority patent/BR112019003957A2/pt
Priority to CA3035159A priority patent/CA3035159A1/en
Priority to PCT/GB2017/052535 priority patent/WO2018042178A1/en
Priority to AU2017319218A priority patent/AU2017319218B2/en
Priority to MX2019002248A priority patent/MX420767B/es
Priority to NZ751995A priority patent/NZ751995B2/en
Priority to JP2019511993A priority patent/JP7525093B2/ja
Priority to CN201780060701.6A priority patent/CN109890412B/zh
Priority to EP17762178.6A priority patent/EP3506934A1/en
Priority to KR1020197008694A priority patent/KR102643280B1/ko
Priority to GB1903866.0A priority patent/GB2568440B/en
Priority to IL265078A priority patent/IL265078B2/en
Priority to ZA2019/01862A priority patent/ZA201901862B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GBGB1614687.0A 2016-08-31 2016-08-31 fHbp scaffold Ceased GB201614687D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB1614687.0A GB201614687D0 (en) 2016-08-31 2016-08-31 fHbp scaffold
GB1903866.0A GB2568440B (en) 2016-08-31 2017-08-31 Modified factor H binding protein
MX2019002248A MX420767B (es) 2016-08-31 2017-08-31 Proteina de union al factor h modificada
JP2019511993A JP7525093B2 (ja) 2016-08-31 2017-08-31 改変ｈ因子結合タンパク質
CA3035159A CA3035159A1 (en) 2016-08-31 2017-08-31 Modified factor h binding protein
PCT/GB2017/052535 WO2018042178A1 (en) 2016-08-31 2017-08-31 Modified factor h binding protein
AU2017319218A AU2017319218B2 (en) 2016-08-31 2017-08-31 Modified factor H binding protein
US16/328,340 US12497432B2 (en) 2016-08-31 2017-08-31 Modified factor H binding protein
NZ751995A NZ751995B2 (en) 2017-08-31 Modified factor h binding protein
BR112019003957-0A BR112019003957A2 (pt) 2016-08-31 2017-08-31 proteína de ligação a fator h modificado
CN201780060701.6A CN109890412B (zh) 2016-08-31 2017-08-31 修饰的因子h结合蛋白
EP17762178.6A EP3506934A1 (en) 2016-08-31 2017-08-31 Modified factor h binding protein
KR1020197008694A KR102643280B1 (ko) 2016-08-31 2017-08-31 변형된 인자 h 결합 단백질
IL265078A IL265078B2 (en) 2016-08-31 2019-02-27 Adapted protein that binds factor h
ZA2019/01862A ZA201901862B (en) 2016-08-31 2019-03-26 Modified factor h binding protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1614687.0A GB201614687D0 (en) 2016-08-31 2016-08-31 fHbp scaffold

Publications (1)

Publication Number Publication Date
GB201614687D0 true GB201614687D0 (en) 2016-10-12

Family

ID=57119942

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1614687.0A Ceased GB201614687D0 (en) 2016-08-31 2016-08-31 fHbp scaffold
GB1903866.0A Active GB2568440B (en) 2016-08-31 2017-08-31 Modified factor H binding protein

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1903866.0A Active GB2568440B (en) 2016-08-31 2017-08-31 Modified factor H binding protein

Country Status (13)

Country Link
US (1) US12497432B2 (https=)
EP (1) EP3506934A1 (https=)
JP (1) JP7525093B2 (https=)
KR (1) KR102643280B1 (https=)
CN (1) CN109890412B (https=)
AU (1) AU2017319218B2 (https=)
BR (1) BR112019003957A2 (https=)
CA (1) CA3035159A1 (https=)
GB (2) GB201614687D0 (https=)
IL (1) IL265078B2 (https=)
MX (1) MX420767B (https=)
WO (1) WO2018042178A1 (https=)
ZA (1) ZA201901862B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
CN110903400A (zh) * 2019-11-08 2020-03-24 苏州微超生物科技有限公司 B群脑膜炎球菌fHBP多变体融合蛋白及其制备方法与应用
CN111533792B (zh) 2020-07-07 2020-10-16 康希诺生物股份公司 一种定点突变的载体蛋白及其在制备疫苗中的用途
WO2022071291A1 (ja) * 2020-09-29 2022-04-07 出光興産株式会社 ペプチドタグおよびそれを含むタグ付加タンパク質
IN202321021121A (https=) * 2023-03-24 2024-04-19

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX339524B (es) * 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
US7351413B2 (en) * 2002-02-21 2008-04-01 Lorantis, Limited Stabilized HBc chimer particles as immunogens for chronic hepatitis
US7785608B2 (en) * 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
HUE031886T2 (en) * 2002-10-11 2017-08-28 Glaxosmithkline Biologicals Sa Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
AU2003300841B2 (en) * 2002-12-10 2008-03-20 Lorantis Ltd. Stabilized immunogenic HBc chimer particles
EP2172213B1 (en) * 2003-01-30 2013-04-03 Novartis AG Injectable vaccines against multiple meningococcal serogroups
NZ546430A (en) * 2003-10-02 2009-04-30 Novartis Vaccines & Diagnostic Liquid vaccines for multiple meningococcal serogroups
GB0408977D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
CA2574375C (en) * 2004-07-23 2015-03-17 Chiron Srl Polypeptides for oligomeric assembly of antigens
GB0419408D0 (en) * 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
WO2006081259A2 (en) * 2005-01-27 2006-08-03 Children's Hospital & Research Center At Oakland Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
EP1925318A1 (en) * 2006-11-20 2008-05-28 Paul-Ehrlich-Institut Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu
CN102356089B (zh) * 2008-02-21 2014-02-19 诺华股份有限公司 脑膜炎球菌fHBP多肽
AU2009223613B2 (en) * 2008-03-10 2014-09-25 Children's Hospital & Research Center At Oakland Chimeric factor H binding proteins (fHBP) containing a heterologous B domain and methods of use
UA99659C2 (uk) * 2008-05-30 2012-09-10 Дзе Ю.Ес.Ей., Ес Репрезентед Бай Дзе Секретарі Оф Дзе Армі, Он Бехаф Оф Уолтер Рід Армі Мультивалентна вакцина з нативних везикул зовнішньої мембрани менінгококів, способи її застосування
EP2294085A1 (en) * 2008-06-09 2011-03-16 Novartis AG Antibodies against neisserial factor h binding protein
EP2331562A4 (en) * 2008-09-03 2012-07-04 Childrens Hosp & Res Ct Oak PEPTIDES WITH AN EPITOPE OF A DOMAIN OF THE FACTOR H-BINDING PROTEIN AND METHOD OF USE
GB0819633D0 (en) * 2008-10-25 2008-12-03 Isis Innovation Composition
EP2411048B1 (en) * 2009-03-24 2020-05-06 GlaxoSmithKline Biologicals SA Adjuvanting meningococcal factor h binding protein
CA2759400A1 (en) * 2009-04-30 2010-11-04 Children's Hospital & Research Center At Oakland Chimeric factor h binding proteins (fhbp) and methods of use
CN102596240B (zh) * 2009-08-27 2015-02-04 诺华股份有限公司 包括脑膜炎球菌fHBP序列的杂交多肽
CA2779816A1 (en) * 2009-10-27 2011-05-05 Novartis Ag Modified meningococcal fhbp polypeptides
CA2792687A1 (en) * 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
TR201802933T4 (tr) * 2010-03-30 2018-03-21 Childrens Hospital & Res Center At Oakland Özellikleri değiştirilmiş faktör h bağlama proteinleri (fhbp) ve bunların kullanım yöntemi.
WO2011125015A2 (en) * 2010-04-05 2011-10-13 Bar-Ilan University Protease-activatable pore-forming polypeptides
AU2011268507B2 (en) * 2010-06-25 2014-08-14 Novartis Ag Combinations of meningococcal factor H binding proteins
AU2011300409B2 (en) * 2010-09-10 2015-03-26 Wyeth Llc Non-lipidated variants of Neisseria meningitidis ORF2086 antigens
GB201015132D0 (en) * 2010-09-10 2010-10-27 Univ Bristol Vaccine composition
WO2013078223A1 (en) * 2011-11-23 2013-05-30 Children's Hospital & Research Center Oakland Anti-factor h binding protein antibodies and methods of use thereof
JP2015505309A (ja) * 2011-12-29 2015-02-19 ノバルティス アーゲー 髄膜炎菌ｈ因子結合タンパク質のアジュバントされた組み合わせ
US10598666B2 (en) * 2012-03-08 2020-03-24 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines
SA115360586B1 (ar) * 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
MY198910A (en) * 2012-03-09 2023-10-02 Pfizer Neisseria meningitidis compositions and methods thereof
AU2013276083B2 (en) * 2012-06-14 2018-04-05 Institut Pasteur Vaccines for serogroup X meningococcus
GB201215005D0 (en) * 2012-08-23 2012-10-10 Isis Innovation Stabilised meningitis vaccine
WO2014136064A2 (en) * 2013-03-08 2014-09-12 Pfizer Inc. Immunogenic fusion polypeptides
WO2014140562A1 (en) * 2013-03-14 2014-09-18 Isis Innovation Limited Immunogenic composition to neisseria
RU2662968C2 (ru) * 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
KR20160127104A (ko) * 2014-02-28 2016-11-02 글락소스미스클라인 바이오로지칼즈 에스.에이. 변형된 수막구균 fhbp 폴리펩티드
KR102761870B1 (ko) * 2014-07-23 2025-02-05 칠드런즈 하스피틀 앤드 리써치 센터 앳 오클랜드 인자 h 결합 단백질 변이체 및 이의 사용 방법
CA2967139A1 (en) * 2014-11-28 2016-06-02 Janssen Vaccines & Prevention B.V. Meningitis b vaccine
WO2016132294A1 (en) * 2015-02-19 2016-08-25 Pfizer Inc. Neisseria meningitidis compositions and methods thereof
GB201614687D0 (en) * 2016-08-31 2016-10-12 Univ Oxford Innovation Ltd fHbp scaffold
AU2018215585B2 (en) * 2017-01-31 2022-03-17 Pfizer Inc. Neisseria meningitidis compositions and methods thereof

Also Published As

Publication number Publication date
BR112019003957A2 (pt) 2019-06-25
ZA201901862B (en) 2020-09-30
KR102643280B1 (ko) 2024-03-05
JP7525093B2 (ja) 2024-07-30
CN109890412B (zh) 2025-04-04
CN109890412A (zh) 2019-06-14
NZ751995A (en) 2024-03-22
MX2019002248A (es) 2019-09-18
MX420767B (es) 2025-02-10
AU2017319218B2 (en) 2021-10-28
GB2568440B (en) 2022-08-17
IL265078B2 (en) 2023-08-01
EP3506934A1 (en) 2019-07-10
GB2568440A (en) 2019-05-15
KR20190064577A (ko) 2019-06-10
JP2019526261A (ja) 2019-09-19
US20220112249A1 (en) 2022-04-14
WO2018042178A1 (en) 2018-03-08
GB201903866D0 (en) 2019-05-08
AU2017319218A1 (en) 2019-04-18
US12497432B2 (en) 2025-12-16
CA3035159A1 (en) 2018-03-08
AU2017319218A2 (en) 2019-05-02
IL265078A (https=) 2019-04-30
IL265078B1 (en) 2023-04-01

Similar Documents

Publication Publication Date Title
AU201616677S (en) Cylindres
PL3221519T3 (pl) Układ rusztowaniowy
GB201612093D0 (en) Combination
GB201614687D0 (en) fHbp scaffold
GB2549996B (en) Structures
GB2536629B (en) Adjustable scaffold
GB201622416D0 (en) Tissue scaffold
GB201616014D0 (en) Combination
GB201608356D0 (en) Formulation
GB2550676B (en) Structural Support-Frameworks
PL3516135T3 (pl) Okucie
GB201608684D0 (en) Scaffold
GB201707615D0 (en) Formulation
GB201610869D0 (en) Combination
GB201809488D0 (en) Scaffold
AU201715086S (en) Scaffolding
PL3559185T3 (pl) Preparat nabłyszczający
GB2591055B (en) Fitting
GB201517697D0 (en) Scaffold
GB201616909D0 (en) Combination
AU2016361V (en) JCU8 Desmanthus virgatus
AU2016360V (en) JCU7 Desmanthus leptophyllus
AU2016359V (en) JCU6 Desmanthus bicornutus
GB201509529D0 (en) Scaffold
AU201616673S (en) tallboy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)